Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M500721200 on April 7, 2005

J. Biol. Chem., Vol. 280, Issue 23, 22172-22180, June 10, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/23/22172    most recent
M500721200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McLaughlin, J. N.
Right arrow Articles by Hamm, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLaughlin, J. N.
Right arrow Articles by Hamm, H. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells*{boxs}

Joseph N. McLaughlin{ddagger}§, Maria R. Mazzoni{ddagger}||§, John H. Cleator{ddagger}**{ddagger}{ddagger}, Laurie Earls{ddagger}, Ana Luisa Perdigoto{ddagger}, Joshua D. Brooks{ddagger}, James A. S. Muldowney, III**§§, Douglas E. Vaughan**, and Heidi E. Hamm{ddagger}

From the {ddagger}Department of Pharmacology and **Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232 and ||Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Pisa, 56126, Italy

Thrombospondin-1 (THBS1) is a large extracellular matrix glycoprotein that affects vasculature systems such as platelet activation, angiogenesis, and wound healing. Increases in THBS1 expression have been liked to disease states including tumor progression, atherosclerosis, and arthritis. The present study focuses on the effects of thrombin activation of the G-protein-coupled, protease-activated receptor-1 (PAR-1) on THBS1 gene expression in the microvascular endothelium. Thrombin-induced changes in gene expression were characterized by microarray analysis of ~11,000 different human genes in human microvascular endothelial cells (HMEC-1). Thrombin induced the expression of a set of at least 65 genes including THBS1. Changes in THBS1 mRNA correlated with an increase in the extracellular THBS1 protein concentration. The PAR-1-specific agonist peptide (TFLLRNK-PDK) mimicked thrombin stimulation of THBS1 expression, suggesting that thrombin signaling is through PAR-1. Further studies showed THBS1 expression was sensitive to pertussis toxin and protein kinase C inhibition indicating Gi/o- and Gq-mediated pathways. THBS1 up-regulation was also confirmed in human umbilical vein endothelial cells stimulated with thrombin. Analysis of the promoter region of THBS1 and other genes of similar expression profile identified from the microarray predicted an EBOX/EGRF transcription model. Expression of members of each family, MYC and EGR1, respectively, correlated with THBS1 expression. These results suggest thrombin formed at sites of vascular injury increases THBS1 expression into the extracellular matrix via activation of a PAR-1, Gi/o, Gq, EBOX/EGRF-signaling cascade, elucidating regulatory points that may play a role in increased THBS1 expression in disease states.


Received for publication, January 20, 2005 , and in revised form, March 14, 2005.

* This work was supported in part by the National Institutes of Health Grant 5 RO1 HL60906-04. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains supplemental material.

§ These authors contributed equally to this work.

{ddagger}{ddagger} Supported by American Medical Association Post-doctoral Award 0325373B.

§§ Supported by National Institutes of Health Grant 5T32 HL07411-23 and The Stanley J. Sarnoff Endowment for Cardiovascular Research.

Supported by National Institutes of Health Grant 5T32 HL07751-11. To whom correspondence should be addressed: Dept. of Pharmacology, Vanderbilt University Medical Center, 444 Robinson Research Bldg., 23rd Ave. South at Pierce, Nashville, TN 37232-6600. Tel.: 615-936-0736; Fax: 615-322-5117; E-mail: joseph.mclaughlin{at}vanderbilt.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
P. Ghafoori, T. Yoshimura, B. Turpie, and S. Masli
Increased I{kappa}B{alpha} expression is essential for the tolerogenic property of TGF-{beta}-exposed APCs
FASEB J, July 1, 2009; 23(7): 2226 - 2234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. S. Blackburn and C. E. Brinckerhoff
Matrix Metalloproteinase-1 and Thrombin Differentially Activate Gene Expression in Endothelial Cells via PAR-1 and Promote Angiogenesis
Am. J. Pathol., December 1, 2008; 173(6): 1736 - 1746.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Y. Kai, K. Hirano, Y. Maeda, J. Nishimura, T. Sasaki, and H. Kanaide
Prevention of the Hypercontractile Response to Thrombin by Proteinase-Activated Receptor-1 Antagonist in Subarachnoid Hemorrhage
Stroke, December 1, 2007; 38(12): 3259 - 3265.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. Urayama, C. Guilini, N. Messaddeq, K. Hu, M. Steenman, H. Kurose, G. Ert, and C. G. Nebigil
The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis
FASEB J, September 1, 2007; 21(11): 2980 - 2993.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. N. McLaughlin, M. M. Patterson, and A. B. Malik
Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization
PNAS, March 27, 2007; 104(13): 5662 - 5667.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Hirano
The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology
Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 27 - 36.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. P. Luyendyk, L. D. Lehman-McKeeman, D. M. Nelson, V. M. Bhaskaran, T. P. Reilly, B. D. Car, G. H. Cantor, X. Deng, J. F. Maddox, P. E. Ganey, et al.
Coagulation-Dependent Gene Expression and Liver Injury in Rats Given Lipopolysaccharide with Ranitidine but Not with Famotidine
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 635 - 643.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Sood, S. Kalloway, A. E. Mast, C. J. Hillard, and H. Weiler
Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells
Blood, April 15, 2006; 107(8): 3173 - 3180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement